ArticlePloS one2016

The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.

Sam Tsz Wai Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.